Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Renaud

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Polish Archives of Internal Medicine|August 26, 2025
Refractory ascites and multinodular systemic involvement led to the discovery of an exceptional multivisceral form of vascular epithelioid tumor associated with the EWSR1::NFATC2 rearrangementArthur Renaud, Louise Galmiche, Antoine Néel
Presse Medicale (Paris, France : 1983)|October 31, 2021
Treatment of systemic sclerosisBenjamin Thoreau, Benjamin Chaigne, Arthur Renaud, et al.
Presse Medicale (Paris, France : 1983)|October 31, 2021
Pathophysiology of systemic sclerosisBenjamin Thoreau, Benjamin Chaigne, Arthur Renaud, et al.
QJM : Monthly Journal of the Association of Physicians|July 3, 2025
Cochleovestibular nerve involvement in sarcoidosis: a case series and a literature reviewTristan Dietrich, Arthur Renaud, Gwenvael Danic, et al.
BMC Pulmonary Medicine|January 26, 2022
Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomographyArthur Renaud, Raphael Pautre, Olivier Morla, et al.
Plos One|November 19, 2021
Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpuraArthur Renaud, Aurélie Caristan, Amélie Seguin, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Polish Archives of Internal Medicine|August 26, 2025
Refractory ascites and multinodular systemic involvement led to the discovery of an exceptional multivisceral form of vascular epithelioid tumor associated with the EWSR1::NFATC2 rearrangementArthur Renaud, Louise Galmiche, Antoine Néel
Presse Medicale (Paris, France : 1983)|October 31, 2021
Treatment of systemic sclerosisBenjamin Thoreau, Benjamin Chaigne, Arthur Renaud, et al.
Presse Medicale (Paris, France : 1983)|October 31, 2021
Pathophysiology of systemic sclerosisBenjamin Thoreau, Benjamin Chaigne, Arthur Renaud, et al.
QJM : Monthly Journal of the Association of Physicians|July 3, 2025
Cochleovestibular nerve involvement in sarcoidosis: a case series and a literature reviewTristan Dietrich, Arthur Renaud, Gwenvael Danic, et al.
BMC Pulmonary Medicine|January 26, 2022
Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomographyArthur Renaud, Raphael Pautre, Olivier Morla, et al.
Plos One|November 19, 2021
Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpuraArthur Renaud, Aurélie Caristan, Amélie Seguin, et al.
Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.
Journal of Autoimmunity|October 16, 2025
Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)François Barde, Kevin Chevalier, Paul Decker, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Pageof 1